Study reveals potential targets to improve the treatment of myeloma

A ground-breaking study by researchers from the Cancer Science Institute of Singapore (CSI Singapore) at the National University of Singapore (NUS) has revealed crucial insights into the role of the histone methyltransferase NSD2 and its epigenetic target PKCα in causing t(4;14) translocated multiple myeloma (MM), a high-risk subtype of blood cancer, to be more aggressive and resistant to treatment.

Emphasizing workforce diversity in the One Health approach

A new article highlights a critical issue in the One Health approach-;an emerging global framework for tackling complex health challenges at the intersection of human,

October 12, 2024

Alzheimer’s genetic risk studies undermined by systemic biases

Recent research in Nature Genetics reveals pervasive biases in GWAX studies using parental history of Alzheimer’s, highlighting potential misdirection in genetic associations and disease risk

December 5, 2024

Meta Title: Ablynx NV Patent: Inhibiting Tumor Growth with GITR-Binding Polypeptides

Share this article According to GlobalData’s company profile on Ablynx, was a key innovation area identified from patents. Inhibiting tumor growth by administering polypeptides binding

April 15, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.